Catechins as Tools to Understand the Molecular Basis of Neurodegeneration

被引:34
|
作者
Pomier, Karla Martinez [1 ]
Ahmed, Rashik [2 ]
Melacini, Giuseppe [1 ,2 ]
机构
[1] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada
[2] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada
来源
MOLECULES | 2020年 / 25卷 / 16期
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Alzheimer's Disease; amyloid beta; catechin; EGCG; NMR; alpha-synuclein; GREEN TEA CATECHINS; HUMAN SERUM-ALBUMIN; A-BETA-PEPTIDE; ATOMIC-RESOLUTION MAP; FORMATION IN-VITRO; ALPHA-SYNUCLEIN; AMYLOID-BETA; EPIGALLOCATECHIN GALLATE; POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ALZHEIMERS-DISEASE;
D O I
10.3390/molecules25163571
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding as well as the subsequent self-association and deposition of amyloid aggregates is implicated in the progression of several neurodegenerative disorders including Alzheimer's and Parkinson's diseases. Modulators of amyloidogenic aggregation serve as essential tools to dissect the underlying molecular mechanisms and may offer insight on potential therapeutic solutions. These modulators include green tea catechins, which are potent inhibitors of amyloid aggregation. Although catechins often exhibit poor pharmacokinetic properties and bioavailability, they are still essential tools for identifying the drivers of amyloid aggregation and for developing other aggregation modulators through structural mimicry. As an illustration of such strategies, here we review how catechins have been used to map the toxic surfaces of oligomeric amyloid-like species and develop catechin-based phenolic compounds with enhanced anti-amyloid activity.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Unraveling the Molecular Mechanisms Behind the Metabolic Basis of Sporadic Alzheimer's Disease
    Erol, Adnan
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) : 267 - 276
  • [32] Molecular toxicity of aluminium in relation to neurodegeneration
    Vasudevaraju, Bharathi P.
    Govindaraju, M.
    Palanisamy, A. P.
    Sambamurti, K.
    Rao, K. S. J.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2008, 128 (04) : 545 - 556
  • [33] Neuron-glia interactions: Molecular basis of alzheimer's disease and applications of neuroproteomics
    Ibrahim, Abdallah Mohammad
    Pottoo, Faheem Hyder
    Dahiya, Ekta Singh
    Khan, Firdos Alam
    Kumar, J. B. Senthil
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2020, 52 (02) : 2931 - 2943
  • [34] Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies
    Nakano, Shogo
    Megro, Shin-ichi
    Hase, Tadashi
    Suzuki, Takuji
    Isemura, Mamoru
    Nakamura, Yoriyuki
    Ito, Sohei
    MOLECULES, 2018, 23 (08):
  • [35] Yeast proteinopathy models: a robust tool for deciphering the basis of neurodegeneration
    Shrestha, Amit
    Megeney, Lynn A.
    MICROBIAL CELL, 2015, 2 (12): : 458 - 465
  • [36] Protein Quality Control by Molecular Chaperones in Neurodegeneration
    Ciechanover, Aaron
    Kwon, Yong Tae
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [37] Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
    Witt, Stephan N.
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 552 - 560
  • [38] An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer's disease: targeting molecular approach Nrf2, NF-κB, and CREB
    Bhardwaj, Shaveta
    Grewal, Amarjot Kaur
    Singh, Shamsher
    Dhankar, Vaibhav
    Jindal, Anu
    INFLAMMOPHARMACOLOGY, 2024, 32 (05) : 2943 - 2960
  • [39] Molecular estimation of neurodegeneration pseudotime in older brains
    Mukherjee, Sumit
    Heath, Laura
    Preuss, Christoph
    Jayadev, Suman
    Garden, Gwenn A.
    Greenwood, Anna K.
    Sieberts, Solveig K.
    De Jager, Philip L.
    Ertekin-Taner, Nilufer
    Carter, Gregory W.
    Mangravite, Lara M.
    Logsdon, Benjamin A.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [40] Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
    Stephan N. Witt
    Molecular Neurobiology, 2013, 47 : 552 - 560